142
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Aerosolized recombinant human lysozyme enhances the bactericidal effect of tobramycin in a hamster model of pseudomonas aeruginosa–induced pneumonia

, , &
Pages 536-541 | Received 18 Apr 2011, Accepted 28 Jul 2011, Published online: 03 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Karl E Griswold, Jenna L Bement, Charlotte C Teneback, Thomas C Scanlon, Matthew J Wargo & Laurie W Leclair. (2014) Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections. Bioengineered 5:2, pages 143-147.
Read now
Paul Zarogoulidis, Ioannis Kioumis, Konstantinos Porpodis, Dionysios Spyratos, Kosmas Tsakiridis, Haidong Huang, Qiang Li, J Francis Turner, Robert Browning, Wolfgang Hohenforst-Schmidt & Konstantinos Zarogoulidis. (2013) Clinical experimentation with aerosol antibiotics: current and future methods of administration. Drug Design, Development and Therapy 7, pages 1115-1134.
Read now

Articles from other publishers (13)

María Escobar‐Salom, Gabriel Torrens, Elena Jordana‐Lluch, Antonio Oliver & Carlos Juan. (2022) Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug‐resistant Gram ‐negatives . Biological Reviews 97:3, pages 1005-1037.
Crossref
Yuncheng Wang, Rachel Yoon Kyung Chang, Warwick J. Britton & Hak-Kim Chan. (2022) Advances in the development of antimicrobial peptides and proteins for inhaled therapy. Advanced Drug Delivery Reviews 180, pages 114066.
Crossref
Patrizia Ferraboschi, Samuele Ciceri & Paride Grisenti. (2021) Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic. Antibiotics 10:12, pages 1534.
Crossref
Gabriel Torrens, Maria Escobar-Salom, Antonio Oliver & Carlos Juan. (2020) Activity of mammalian peptidoglycan-targeting immunity against Pseudomonas aeruginosa. Journal of Medical Microbiology 69:4, pages 492-504.
Crossref
Lise Schoonen, Sjors Maassen, Roeland J. M. Nolte & Jan C. M. van Hest. (2017) Stabilization of a Virus-Like Particle and Its Application as a Nanoreactor at Physiological Conditions. Biomacromolecules 18:11, pages 3492-3497.
Crossref
Milankumar V Prajapati, Olujoba O Adebolu, Benjamin M Morrow & Joseph M Cerreta. (2016) Original Research: Evaluation of pulmonary response to inhaled tungsten (IV) oxide nanoparticles in golden Syrian hamsters. Experimental Biology and Medicine 242:1, pages 29-44.
Crossref
Sarah M. Dostal, Yongliang Fang, Jonathan C. Guerrette, Thomas C. Scanlon & Karl E. Griswold. (2015) Genetically Enhanced Lysozyme Evades a Pathogen Derived Inhibitory Protein. ACS Chemical Biology 10:4, pages 1110-1117.
Crossref
Daniel C. Osipovitch & Karl E. Griswold. (2014) Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent. FEMS Microbiology Letters 362:2, pages 1-7.
Crossref
Vivian Tullio, Roberta Spaccapelo & Manuela Polimeni. 2015. Human and Mosquito Lysozymes. Human and Mosquito Lysozymes 45 57 .
Xiaojie Wu, Yanli Lin, Yongyi Xi, Zhenlu Shao, Yanrong Zhou, Fang Liu & Hongxing Chen. (2014) The development of transgenic mice for the expression of large amounts of human lysozyme in milk. Biotechnology Letters 36:6, pages 1197-1202.
Crossref
Charlotte C. Teneback, Thomas C. Scanlon, Matthew J. Wargo, Jenna L. Bement, Karl E. Griswold & Laurie W. Leclair. (2013) Bioengineered Lysozyme Reduces Bacterial Burden and Inflammation in a Murine Model of Mucoid Pseudomonas aeruginosa Lung Infection. Antimicrobial Agents and Chemotherapy 57:11, pages 5559-5564.
Crossref
Paul Zarogoulidis, Ioannis Kioumis, Christos Ritzoulis, Dimitris Petridis, Kaid Darwiche, Konstantinos Porpodis, Dionysis Spyratos, Scott Parrish, Robert Browning, Qiang Li, J. Francis Turner, Lutz Freitag & Konstantinos Zarogoulidis. (2013) New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam. International Journal of Pharmaceutics 455:1-2, pages 182-188.
Crossref
John W. Lamppa, Sam A. Tanyos & Karl E. Griswold. (2013) Engineering Escherichia coli for soluble expression and single step purification of active human lysozyme. Journal of Biotechnology 164:1, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.